Use of transforming growth factor - beta 1 (TGF-beta1) inhibitor peptides for the treatment of corneal fibrosis and/or haze

Details for Australian Patent Application No. 2011217181 (hide)

Owner PROYECTO DE BIOMEDICINA CIMA, S.L. DIGNA BIOTECH,S.L.

Inventors Dotor De Las Herrerias, Javier; Maldonado Lopez, Miguel Jose

Agent Collison & Co

Pub. Number AU-A-2011217181

PCT Pub. Number WO2011/101478

Priority 12/709,895 22.02.10 US

Filing date 21 February 2011

Wipo publication date 25 August 2011

International Classifications

A61K 38/18 Medicinal preparations containing peptides - Growth factors

A61P 27/02 Drugs for disorders of the senses

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/101478 Priority application(s): WO2011/101478

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011217190-Method and system for disease diagnosis via simultaneous detection of antibodies bound to synthetic and cellular substrates

2011217180-Electrode for electrochemical processes and method for obtaining the same